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Summary Although many studies have been carried
out to verify the involvement of the peripheral nervous
system (PNS) in dystrophia myotonica (DM1) patients,
the results remain controversial. The generation of
DM1 transgenic mice displaying the human DM1 phe-
notype provides a useful tool to investigate the type
and incidence of structural abnormalities in the PNS.
In the present study, the morphological and morpho-
metric analysis of semi-thin sections of sciatic and sural
nerves, lumbar dorsal root ganglia (DRG) and lumbar
spinal cords revealed that in DM1 transgenic mice car-
rying 300 CTG repeats, there is no change in the num-
ber and diameter of myelinated axons compared to
wild type. Only a non-signiWcant reduction in the per-
centage of thin myelinated axons was detected in elec-
tron micrographs of ultra-thin sciatic nerve sections.
Analysis of the number of neurons did not reveal a loss
in number of either sensory neurons in the lumbar
DRG or motor neurons in the lumbar spinal cord in
these DM1 mice. Furthermore, in hind limb muscle
sections, stained with a neuroWlament antibody and
-bungarotoxin, the intramuscular axon arborization
appeared normal in DM1 mice and undistinguishable
from that in wild-type mice. Moreover, in DM1 mice,
there was no irregularity in the structure or an increase
in the endplate area. Also statistical analysis did not
show an increase in endplate density or in the concen-
tration of acetylcholine receptors. Altogether, these
results suggest that 300 CTG repeats are not suYcient
to induce axonopathy, demyelination or neuronopa-
thies in this transgenic mouse model.
Keywords Myotonic dystrophy · Sensory neuropathy · 
DM1 transgenic mice · Morphometric analysis
Introduction
Myotonic dystrophy of Steinert’s disease (or dystro-
phia myotonica, DM1) is an autosomal dominant dis-
order and the commonest form of muscular dystrophy
in adults [16, 17]. DM1 results from the expansion of an
unstable CTG repeat in the 3-untranslated region of
the myotonin-protein kinase (DMPK) gene on chro-
mosome 19q, which codes for a serine/threonine
protein kinase [4, 14, 29] While normal individuals
have between 5–35 CTG repeats, which remain stable
over generations, DM1 aVected patients have 50–150
repeats in the mild form, 100–1,000 repeats in the clas-
sical adult form and >2,000 repeats in the congenital
form. It has been reported that the length of the expan-
sion correlates with the severity of the clinical symp-
toms and age of onset [21, 40, 47].
DM1, which is characterized primarily by myotonia
and muscle weakness, is a multisystemic disease with a
highly variable phenotype. Gastrointestinal smooth
muscle abnormality is the major symptom in many
patients [17, 20, 25]. However, cardiac abnormalities,
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also common complications of DM1 patients [1, 19, 27,
30, 38, 50]. In addition, it has been reported that the
central nervous system is also involved in DM1,
particularly when onset is early. Cognitive distur-
bances, mental retardation, sleep disorders, behav-
ioral changes and diYcult personalities are frequently
observed in congenital type DM1 adult patients [23,
34, 37, 49]. While the involvement of the CNS in DM1
patients is well described, the involvement of the
peripheral nervous system in the DM1 disorder is still
a matter of debate and the Wnal consequence are not
completely known. The detection of sensory-motor
axonal neuropathy in DM1 patients was mainly per-
formed by electrophysiological studies, with almost no
qualitative and quantitative analysis and no animal
model studies. Moreover, there are no systematic
studies showing the correlation between the size of the
unstable CTG repeat and the type of peripheral neu-
ropathy observed in patients. The production of trans-
genic mice carrying a variable number of CTG repeats
oVers the possibility to study the size of CTG repeats,
which could induce structural changes in the periph-
eral nervous system and to determine the types of
peripheral nerve abnormalities related to a precise
length of CTG repeats.
To investigate the incidence and type of possible
structural abnormalities in the peripheral nervous
system, we studied transgenic mice carrying 300 CTG
repeats, which display the human DM1 phenotype.
We compared wild-type and DM1 mice for the
absence or presence of axonal degeneration and
demyelination in sciatic and sural nerves as well as
neuronopathy in the dorsal root ganglia and in the
spinal cord. In addition, the stability of the neuromus-
cular junction was investigated in the hind limb
muscles.
Materials and methods
Generation of DM1 transgenic mice
Transgenic mice carrying the human genomic DM1
region with expanded repeats of approximately 300
CTG (DM1) or with 20 CTG repeats (normal) were
produced and screened as previously described [44,
45]. The homozygous (DM1) transgenic mice display
abnormalities in skeletal muscles, consistent with
those observed in DM1 patients, whereas transgenic
mice expressing 20 repeats (DM20) do not develop
these changes [44, 45] and were used as internal
controls.
Animal perfusion and tissue preparation 
All animal procedures were conducted according to
local guidelines for care and use of experimental
animals.
A total of 36 mice (7–13 months) were used in this
study: 12 DM1 transgenic mice, 12 internal controls
(DM20 transgenic mice) and 12 C57BL/6J wild-type
mice (genetic background of the DM1 transgenic mice).
The mice were deeply anesthetized with pentobarbital
(75 mg/kg), then transcardially perfused with 0.1 M
phosphate-buVered saline (PBS) containing 0.1% hepa-
rin and 0.1% procaine, followed by a mixture of 3%
paraformaldehyde and 1.5% glutaraldehyde in 0.1 M
PBS at pH 7.4. The sciatic and sural nerves, lumbar dor-
sal root ganglia (DRG) as well as the lumbar spinal
cord region were removed from each animal. In addi-
tion, muscles from the hind limb (gastrocnemius, triceps
brachili, rectus femoris, etc.) were taken. All specimens
were Wrst post-Wxed for 2 h at 4°C in the Wxative, then
sciatic and sural nerves, the DRG and spinal cord seg-
ments were placed in 2% osmium tetroxide in PBS for
3 h, followed by dehydration in a series of graded etha-
nol and embedded in Epon. The muscles were Wrst
cryoprotected in 30% sucrose overnight, then frozen in
liquid nitrogen and stored at ¡80°C.
Sciatic and sural nerve section preparation 
for morphological and morphometric analysis 
Semi-thin transverse sections of 1 m were cut from
the common trunk (before dividing into peroneal, tib-
ial and sural branches) of sciatic nerves as well as from
the proximal and distal cutaneous sural nerve stump.
The sections were stained with Toluidine blue for light
microscopic and morphometric analysis. For electron
microscopic evaluation, ultra-thin sections (80 nm)
were cut and stained with uranyl acetate and lead
citrate and mounted onto copper grids for examination
in a Zeiss EM 10C electron microscope. For more his-
tological examination of the sural nerves, cryostat lon-
gitudinal sections of the nerves were prepared and
immunostained with primary polyclonal antibody
(1:200) directed against the 200-kDa neuroWlament
proteins (AB1982, Chemicon international).
Morphometric analysis
All counting and measurements were performed blind
to experimental conditions. 
• Counts of myelinated axons: The number of myelin-
ated axons was estimated on four semi-thin nerve123
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control mice (n = 8) and wild-type mice (n = 8),
using a systematic sampling and the StereoInvestiga-
tor program (MicrobrightWeld Inc). With a cursor,
the position of sampled Wbers in more than 20 sam-
pling boxes of 20 £ 20 m were recorded directly
from the histological sections using a Zeiss Universal
light microscope equipped with a motorized stage, a
Sony 930XP video camera and connected to a Dell
computer. The total number of axons was estimated
by the StereoInvestigator program resulting from
the mean local density multiplied by the surface of
the nerve. More than 600 Wbers per nerve were
recorded.
• Measurement of myelinated axon diameter: On the
same semi-thin sections, the diameter of myelinated
axons was measured. Using Neurolucida software
(MicrobrightWeld Inc), the outline of sampled mye-
linated Wbers was digitized. The diameter of the Wber
was calculated from the perimeter using the Excel
program.
• Percentage of myelinated and unmyelinated axons:
The percentage of myelinated and unmyelinated
axons was calculated from representative electron
micrographs (5,800£) of ultra-thin nerve sections,
which were captured by using electron microscopy
and an image-processing program. From each nerve
section, 20 images were taken from randomly
selected Welds (wild-type n = 4 and DM1 transgenic
mice n = 4) and the number of myelinated and
unmyelinated axons counted using Neurolucida soft-
ware (MicrobrightWeld Inc.). The number of myelin-
ated or unmyelinated Wbers per total number of
Wbers in the nerve section was estimated. On the
same series of representative electron micrographs,
the myelin sheath thickness was measured by sam-
pling with line segments perpendicular to the myelin
sheet contour.
Preparation of DRG and spinal cord sections 
and morphometric assessment
The entire ganglia or spinal cord segments from wild-
type and DM1 mice were cut into serial cross-sections
(1 m thick). The sections were then stained with 0.1%
Toluidine blue for 3 min at 80°C, which allowed better
visualization of nuclei and nucleoli proWles of the neu-
ronal cells.
The physical disector method was used to estimate
the total number of sensory and motor neurons inside
the DRG and the spinal cord lumbar segment. This
method is based on sampling sections, called disector
pairs [46].
From each ganglion, approximately 35 disector pairs
were used. The sections from the same disector pair
were separated by 8 m and the separating distance
between the two consecutive pairs was 30 m. The
estimation of the number of neurons was carried out
using Neurolucida software (MicrobrightWeld Inc.) as
described previously [43]. BrieXy, in each disector pair
the contour of the top section was drawn and neurons
of all sizes with clear, visible nuclei were marked with
an “X” symbol. The lower section was digitized and the
cells with visible nuclei labeled with an “O” symbol.
Then the two sections were Wtted one on the other,
based on their contours and landmarks. The nuclei
present only in the top section (tops) of the disector
pair were taken in account.
The count of the tops was extracted with the Neu-
roexplorer software (MicrobrightWeld Inc.) then divided
by the volume of space bound by the outer surface
of the two sections; this represents the local density
of nuclei. An estimate of the local neuronal number
corresponding to the local ganglion volume (volume of
disector pair incremented with the volume between
two consecutive disector pairs) can then be obtained
by multiplying the estimated local density of nuclei
by the local volume of the ganglion. The total number
per ganglion can be obtained by summing up the
partial numbers obtained for each disector pair.
The total volume was estimated by the Cavalieri’s
method [15].
To estimate the number of motor neurons in the
lumbar spinal cord enlargement, we used the physical
disector method, adapted to the size and distribution
of motor neurons inside the spinal cord. Since some
motor neurons have small nuclei (5.5 m), the distance
between the two sections from the same disector pair is
5 m. For each mouse, 15 disector pairs were used, and
two consecutive pairs were separated by 100 m.
Motor neurons were diVerentiated from glial cells on
the basis of the multipolar cell shape with granular
staining of the Nissl body and large pale nuclei. The
estimation of the number of motor neurons inside
1.6 mm segments of lumbar spinal cord was made in
the same manner as described for sensory neurons.
Preparation of muscle sections for neuromuscular 
junction analysis 
Serial longitudinal cryostat sections (20 m) were
prepared from muscles and mounted on microscope
slides. The sections were incubated for 45 min in 1 g/
ml tetramethylrhodamine-conjugated -bungarotoxin
(-BTX, Molecular probes, USA) at room tempera-
ture. The sections were then washed in PBS and123
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30 min before incubation overnight with the primary
polyclonal antibody (1:200) directed against the 200-kDa
neuroWlament proteins (AB1982, Chemicon interna-
tional). After washing with PBS, the muscle sections
were incubated for 2 h with a 1:200 dilution of the
secondary antibody conjugated to Alexa Xuor 488
(Invitrogen, g & rbA488).
The muscle sections were analyzed under Xuorescent
microscopy (Zeiss, Axioplan 2), and photographed
using an image-acquisition program (Zeiss, Axiovision
with Axiocam HRc). The images were analyzed using
an image-processing program (ImageJ 1.34, NIH, USA)
to measure the size and number of endplates. To avoid
counting and measuring the same junction twice, every
third section was analyzed. The size of each endplate
was delimited by circling the area containing a region of
high acetylcholine receptors (AChRs) labeling. The fre-
quency of endplates was calculated as the number of
neuromuscular junctions (NMJ) per mm2 of muscle.
The intensity of AChRs labeling was also determined by
measuring the average Xuorescence intensity of -BTX
at the NMJ. Images that were used for analysis were
obtained under constant exposure conditions. More
than 400 endplates were measured from four mice from
each experimental condition. All analyses and counts
were performed blinded to the animal genotype.
Statistical analysis
The estimated number of myelinated and nonmyeli-
nated axons, the estimated total number of sensory or
motor neurons and the size of the NMJ in DM1 trans-
genic mice were compared to the values of wild-type
mice, using the hierarchical ANOVA test. P · 0.05 was
considered signiWcant. Statistical analysis was carried
out using SAS software (SAS Institute Inc., Cary, NC,
USA) and the general linear model procedure.
Results
Morphological and morphometric analysis 
of the sciatic and sural nerves
Since axonal degeneration is the most common patho-
logic change seen in peripheral neuropathy, we Wrst
examined the sciatic nerves in three diVerent mouse
lines: DM1 diseased mice displaying skeletal muscle
abnormalities, control mice that do not develop muscle
changes and wild-type mice.
Light microscopic examination of transverse semi-
thin sections, taken from the common trunk of sciatic
nerves, showed no diVerence in nerve structure
between DM1 diseased, control and wild-type mice. In
the three animal groups, the sciatic nerves consisted of
four fascicules; each of them surrounded by thin peri-
neurium containing bundles of large myelinated axons
intermingled with bundles of small myelinated Wbers
(Fig. 1a–c). Examination of nerve sections at higher
magniWcation conWrmed the absence of changes in the
sciatic nerve of DM1 mice, features of demyelination
or Wallerian degeneration, and no increase in inXam-
matory or Schwann cell nuclei (Fig. 1d–f).
Fig. 1 Transverse semi-thin sections (1 m thick) from the com-
mon trunk of sciatic nerves taken from wild-type mice (a, d), con-
trol mice (b, e) and DM1 transgenic mice (c, f). The low
magniWcation shows that there is no change in the number and
size of fascicules in DM1 transgenic mice compared to controls.
At high magniWcation, bundles of large axons intermingled with
small axons can be seen in the three nerve sections; note that there
is no obvious structural abnormality in DM1 transgenic mice (f)123
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sciatic nerves revealed no reduction in the number of
myelinated Wbers in DM1 mice (Fig. 2a). The statistical
analysis of the counting results (16 sections, n = 8)
clearly showed that the mean number of myelinated
axons in DM1 mice was equal to that of control and
wild-type mice. Moreover, the measurement of myelin-
ated Wber diameter on the same sections showed a
comparable size–frequency distribution of axons in
DM1, control and wild-type mice (Fig. 2b). In the three
diVerent mouse lines, the histogram distribution was
unimodal with higher frequencies between 6 and 8 m.
The electron microscopic examination of numerous
ultra-thin sciatic nerve sections conWrmed the absence
of signiWcant pathological changes in DM1 mice (Fig. 3).
The classical signs of pathology, such as aberrant
Schwann cell proliferation, Schwann cell onion bulb
formation and Büngner bands were not observed in the
sciatic nerve sections of DM1 mice. The presence of
multiple, unmyelinated axons, closely packed and
enclosed by a single Schwann cell can be seen in DM1
mice as well as in wild-type mice (Fig. 3).
Although the morphological studies did not show
speciWc pathological signs, counting of myelinated
and unmyelinated Wbers on ultra-thin nerve sections
revealed a slight reduction in the percentage of myelin-
ated Wbers in DM1 mice. Of the 7,000 Wbers counted
from 80 electron micrographs of each mouse line, we
found 36.2 § 3.22% myelinated Wbers in DM1 mice
and 42.6 § 6.3% in wild-type mice relative to the total
number of Wbers counted on the whole surface of the
nerve section. Statistical analysis revealed that this
slight reduction is not signiWcant. Moreover, the proWle
of the distribution of myelin sheath thickness in DM1
mice is close to that of controls.
Likewise, histological examination of cryostat and
semi-thin sections prepared from proximal and distal
stumps of sural nerves showed that in either DM1 or
wild-type mice, the proximal nerve segment consisted
of a single fascicle, while the distal segments consisted
of three or more small fascicles. Inside the sural nerve
fascicles of DM1 mice, no evident axonal degenera-
tion or other pathological signs were observed. In
addition, the morphometric analysis of semi-thin
sections revealed that there was no diVerence either in
the diameter or in the mean number of myelinated
Wbers between DM1 (460 § 35) and wild-type mice
(456 § 26).
Morphological and morphometric analysis of sensory 
and motor neurons in lumbar DRGs and spinal cord 
segments
The cell bodies of axons are primarily aVected in
neuronopathy and, therefore, we examined sensory
neurons in DRGs and motor neurons in lumbar spinal
cord segments.
The histological examination of DRG semi-thin sec-
tions of DM1 mice showed that sensory neurons did
not display cytoplasmic features of apoptosis such as
nuclear eccentricity, pyknosis, granulation, vacuolation
and membrane irregularities. Neurons displayed nor-
mal histological shape, with clear Nissl bodies and
large pale nuclei with one or two clear nucleoli (Fig. 4).
To investigate a loss of sensory neurons, we used the
physical disector method to estimate the total number
of sensory neurons in lumbar DRG. As sensory neu-
rons are unevenly distributed in the DRG, about 35
disector pairs covering the entire ganglion were used.
The estimated number of sensory neurons per ganglion
calculated from eight lumbar DRG clearly revealed no
signiWcant changes in the mean total number of sensory
Fig. 2 Bar graph illustrating the mean number (§SD) of myelin-
ated axons counted on two semi-thin sciatic nerve sections per
mouse taken from wild-type mice (n = 8), control mice (n = 8)
and DM1 transgenic mice (n = 8). The statistical analysis demon-
strated that there is no signiWcant diVerence in the mean number
of axons between DM1 mice and controls (a). Size–frequency dis-
tribution of myelinated axons’ diameters, measured on the same
sciatic nerve sections (b). In the three mouse lines, a comparable
distribution of myelinated axons with one peak (size 6–8 m) can
be observed123
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pared to wild-type (3,985 § 882) mice. Microscopic
examination at low magniWcation (2.5£) of lumbar
spinal cord semi-thin sections showed no detectable
changes in the aspect and size of white and gray matter
in DM1 mice compared to wild-type mice (Fig. 5). At
higher magniWcation (10£), small and large motor neu-
rons in the anterior horn of the DM1 spinal cords
appeared normal and free from degeneration features
(Fig. 5d). The estimation of the number of these neu-
rons by the physical disector method revealed that the
mean number of motor neurons in a 1.6 mm lumbar
spinal cord segment was identical in DM1 (4,363 §
1,331) and in wild-type mice (4,174 § 1,346).
Morphological and morphometric analysis 
of neuromuscular junctions 
Histological examination of hind limb muscle sections
showed that AChR clusters were observed in all the
examined sections of DM1 and wild-type mice. In both
mouse lines, some muscle sections showed fascicules of
neuroWlament immunopositive Wbers, oriented parallel
to the muscle Wbers. The axons give rise to some
branches and each branch innervates muscle Wbers at a
single motor endplate (Fig. 6). Therefore, the axon
arborization is normal in DM1 transgenic mice as
observed in control mice.
Examination of muscle sections at higher magniWca-
tion demonstrated that in both DM1 mice or wild-type
mice, most of the endplates were typical with AChRs
concentrated in a pretzel-like pattern. Other small and
simple NMJ shapes were also observed in the two
mouse lines (Fig. 6). Thus, the NMJ observed in DM1
transgenic mice were similar in shape and complexity
to those in control mice. The endplate size frequency
distribution (Fig. 7a) and the mean endplate area in
DM1 mice was comparable to those in wild-type mice.
In fact, the mean major endplate diameter (Feret’s
diameter) in DM1 is 35 § 2.3 m and in controls
37 § 2.3 m. The estimation of the mean number of
NMJ per mm2 of skeletal muscle (density of NMJ) and
the statistical analysis showed that there was no signiW-
cant diVerence between DM1 and wild-type mice
(Fig. 7b). Also, there was no diVerence between wild-
type and DM1 mice in the intensity of AChR
concentration, in the post synaptic membrane, quanti-
tated by measuring the mean Xuorescence intensity of
-BTX in the endplate (Fig. 7c).
Discussion
The present study provides evidence that DM1 mice
carrying the 300 CTG repeat failed to show structural
abnormalities in the peripheral nervous system. The
morphological and morphometric analysis of the sciatic
and sural nerves, dorsal root ganglia and spinal cord in
DM1 mice clearly revealed a lack of axonal degenera-
tion, no signiWcant demyelination and no sensory or
motor neuronopathy. In addition, the histological
examination and the statistical analysis of hind limb
muscles from DM1 mice ruled out abnormalities of
intramuscular nerve endings and of neuromuscular
junction structures. These results suggest that the small
length (300) of the CTG repeat in DM1 mice is
not suYcient to induce peripheral sensory-motor
neuropathy.
Fig. 3 Representative 
electron micrographs of thin 
sections of transverse nerve 
taken from wild-type (a, c) 
and from DM1 transgenic 
mice (b, d). In both mouse 
lines (a, b), numerous unmy-
elinated axons surrounded by 
a Schwann cell intermingled 
with normal myelinated 
Wbers. In DM1 mice, the large 
myelinated axons (d) showed 
a diameter and myelin 
thickness comparable to those 
in wild-type mice (c)123
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organs in DM1 is well documented, a doubt still exists
about the genuine involvement of the peripheral ner-
vous system in DM1. Since 1950, conXicting results
concerning the involvement of the peripheral nervous
system in DM1 have been reported. While both mild
and severe impairment of nerve conduction has been
reported in DM1 patients by several authors [3, 5, 10,
22, 24, 33, 42, 51, 54], others denied the presence of
peripheral neuropathy in DM1 patients [6, 12, 39] or
provided evidence that there was no relationship
between the degree of neurogenic involvement and the
severity of muscular atrophy [11, 32, 35, 36, 53]. More-
over, the histological and morphometric analysis of
nerve biopsies are scanty in human studies and have
provided contrasting results. While no changes in the
peripheral nerves and in the number of spinal cord
motor neurons were reported [9, 39], abnormalities in
distal nerve Wbers and intramuscular bundles are
described by others [3, 7, 8, 28]. It is necessary to
emphasize that these studies, which have conWrmed or
denied association of peripheral neuropathy to DM1
Fig. 4 Micrographs of two DRG sections from the same disector
pair of a wild-type mice: a top section, b neurolucida drawing of
the two sections superimposed on the micrograph of the bottom
section and c bottom section showing the retained proWles. All
nuclei that appeared on the top section are labeled with X
symbol, the nuclei that appeared in the bottom section are
labeled with O symbol and the nuclei that appeared in both
sections are labeled with both X and O symbols. The nuclei that
appear only in the top section and not in the bottom section (tops)
are indicated by arrows
Fig. 5 Micrographs of transverse semi-thin sections of lumbar
spinal cord taken from wild-type (a, c) and DM1 transgenic mice
(b, d). No reduction in DM1 spinal cord size was noted (a and b).
Additionally, the motor neurons in the anterior horn of DM1 (d)
spinal cord appeared similar to those observed in wild-type mice
(c); they are normal and free of degeneration features123
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ship between the length of the CTG repeat and the
presence or absence of neuropathy in patients. There-
fore, an association between neuropathy and DM1
remains open, and the possible types, frequencies and
extents of peripheral nerve abnormalities in DM1
could be studied and clariWed in the various transgenic
mice models carrying deWned lengths of CTG repeats.
The creation of animal models for human genetic
diseases allows the study of structural changes in
several tissues, which cannot usually be performed
directly on patients [55]. Among the several animal
models created for DM1, the transgenic mice
generated by Seznec et al. [44, 45] are extremely valu-
able. Numerous histological, molecular and electro-
myographic analyses [44, 45] show that transgenic
mice, which carry a deWned CTG expansion as in the
human DM1 context (>45 kb) and produce the abnor-
mal DMPK mRNA with at least 300 CUG repeats,
display DM1 phenotypic abnormalities: i.e., (1) growth
retardation and abnormal posture, (2) crossed teeth
and anal prolapse, (3) heterogeneity in the diameter of
muscle Wbers, Wbrosis and inWltration of fatty tissue, as
well as large numbers of centro-nucleated muscle Wbers
in the soleus and sternomastoid muscles, (4) atrophy of
the slow muscle Wbers and an increase in the number of
these Wbers, (5) expression of the human DMPK gene
in transgenic mice tissues and (6) detection of myo-
tonic activity in the muscles of the fore and hind legs.
Thus, these DM1 transgenic mice carrying a deWned
number of CTG repeats are a useful tool to detect
whether the peripheral nervous system also displays
structural and morphometric abnormalities.
Since axonal degeneration, demyelination and neu-
ronopathy are the three major pathological processes
that aVect the peripheral nervous system [31], our
eVorts focused on the detection of these processes in
sciatic and sural nerves, DRG and spinal cords from
wild-type and DM1 mice. The results of morphological
and morphometric analysis of semi-thin nerve sections
Fig. 6 Skeletal muscle sections stained with neuroWlament anti-
body (green) and rhodamine -BTX (red). Note that either in
wild-type (a, b) or in DM1 (c, d) mice, each endplate is innervated
by a branch of axon. Representative images of diVerent shapes of
NMJ observed in wild-type (e–h) and DM1 (i–l) mice123
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ber of myelinated Wbers and no signiWcant change in
their diameter, indicating no demyelination or degener-
ation of large myelinated Wbers in sciatic or in sural
nerves. Only a slight, but no signiWcant reduction was
found in the percentage of thin myelinated Wbers
following analysis of sciatic nerve electron micrographs.
This slight reduction may not represent the classical
neuropathy observed in DM1 patients, which aVects
preferentially large myelinated axons described by
some authors [10, 54]. The estimation of the number of
neurons by the physical disector method revealed no
changes in the number of surviving sensory neurons or
motor neurons in DM1 mice compared to the control.
This result rules out a possible association of neuronop-
athies with DM1. Since changes of terminal axons and
endplates have been detected in biopsies of DM1 mus-
cles in patients ([2, 3, 7–9, 28], we speciWcally analyzed
the muscles of wild-type and DM1 mice, and again sys-
tematic histological and morphometric analysis of hind
limb muscle sections did not show striking axonal
sprouting or changes in the size or number of motor
endplates in DM1 mice. This result excludes a defect in
motor innervation of skeletal muscle and a loss of
motor units. Our Wndings therefore rule out the pres-
ence of the three major pathological processes in DM1
transgenic mice carrying 300 CTG repeats. The fact
that these DM1 transgenic mice display human DM1
phenotypes, but not peripheral neuropathies, suggests
that the expansion of 300 CTG repeats may not be suY-
cient to induce clear peripheral sensory-motor disor-
ders. Another explanation is that there is no association
between peripheral neuropathy and DM1 disease. The
Wrst hypothesis seems to us more probable because it is
in agreement with clinical data, which demonstrate that
the size of the CTG repeat region, which increases from
generation to generation, is correlated with the clinical
severity of the disease [18, 47]. Moreover, this hypothe-
sis can also be supported by Wndings of several authors
who reported that the severity of the peripheral
neuropathy associated with DM1 appears to depend
largely on the patient’s age, the stage of the disorder as
well as the time of progression [26, 41, 52, 54]. It has
also been shown that the involvement of the CNS (cog-
nitive impairment, somnolence, apathy, personality,
depression, etc.) in DM1 is more marked in individuals
with large expansions, greater than 1,000 CTG repeats
[13, 47, 48]. Taking these data into consideration, we
believe that 300 CTG repeats are not suYcient to
induce sensory-motor neuropathy in DM1 transgenic
mice. In addition, this hypothesis could explain why in a
same group of patients, some show a severe slowing of
motor and sensory conduction velocities, others mild
abnormalities, and normal sensory conduction in the
other patients [10, 26, 33]. At present, the eVorts of the
group of Dr G. Gourdon focus on the production of
DM1 transgenic mice carrying larger CTG repeats
(700–1,000). We plan to use these transgenic mice in the
near future to conWrm our hypothesis.
Fig. 7 On longitudinal muscle sections stained with -BTX, the
area and the intensity of labeling of 400 endplates (from each
mouse group) were measured. Size–frequency distribution histo-
grams of endplate areas (a). Note that in DM1 mice, the endplate
area is shifted slightly, but not signiWcantly towards smaller
values. Histogram representing the mean number of the end-
plates per mm2 of skeletal muscle (b). The total number of NMJ
was divided by the whole muscle section surface. No signiWcant
diVerence between DM1 and wild-type mice can be observed.
Histogram representing the mean -BTX Xuorescence intensity
per area of endplate (c). The Xuorescence intensity, which reXects
the concentration of AchRs on the post synaptic membrane is
identical in DM1 and in wild-type mice123
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Since the association of peripheral neuropathy with
DM1 is still a matter of debate, we studied DM1 trans-
genic mice carrying 300 CTG repeats to assess the type
and the incidence of structural alterations in sciatic and
sural nerves, dorsal root ganglia and spinal cord. The
morphological and morphometric analysis rule out the
presence of axonal degeneration, demyelination of
large axons and neuronopathy in these DM1 mice. Our
results suggest that 300 CTG repeats are not suYcient
to induce peripheral sensory-motor neuropathy in this
animal model.
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